Tirzepatide
Dual GIP/GLP-1 receptor agonist for advanced metabolic research. Premium quality lyophilized powder.
Product information
- Catalog purity specification
- 99%+
- form
- Lyophilized Powder
- Availability
- In stock
Price and options
- Tirzepatide — 5mg: USD $89.99 — In stock
- Tirzepatide — 10mg: USD $155.00 — In stock
- Tirzepatide — 15mg: USD $199.00 — In stock
- Tirzepatide — 30mg: USD $299.00 — In stock
- Tirzepatide — 60mg: USD $579.00 — In stock
Research-use disclaimer
For laboratory research use only. Not for human consumption. Not intended to diagnose, treat, cure, or prevent any disease.
Product testing documentation
Research information
Tirzepatide Research Review: A Dual GIP and GLP-1 Receptor Agonist for Metabolic Studies
A research-focused overview of tirzepatide, a synthetic dual GIP and GLP-1 receptor co-agonist studied for its incretin mechanism, C20 fatty-diacid design for weekly pharmacokinetics, and effects on insulin secretion, glucagon, and metabolic endpoints.
Certificates of Analysis and supporting laboratory documentation